Non-invasive diagnostic tools for investigating endothelial dysfunction

Current Pharmaceutical Design

Volumn 14, Issue 35, 2008, Pages 3715-3722

  Ghiadoni, Lorenzo ^a   Versari, Daniele ^a   Giannarelli, Chiara ^a   Faita, Francesco ^b   Taddei, Stefano ^a  

^a UNIVERSITY OF PISA   (Italy)

^b INSTITUTE OF CLINICAL PHYSIOLOGY   (Italy)

Author keywords

Endothelium; Large arteries; Microcirculation; Nitric oxide

Indexed keywords

ACETYLCHOLINE; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; N(G),N(G) DIMETHYLARGININE; NITRATE; NITROPRUSSIDE SODIUM; SALBUTAMOL; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; BIOLOGICAL MARKER;

AUTOCRINE EFFECT; CARDIOVASCULAR FUNCTION; CARDIOVASCULAR RISK; CLINICAL PRACTICE; CLINICAL RESEARCH; CORONARY ARTERY DISEASE; DIAGNOSTIC ACCURACY; DIGITAL PULSE AMPLITUDE TONOMETRY; DRUG DELIVERY SYSTEM; ENDOTHELIAL DYSFUNCTION; ENDOTHELIAL STEM CELL; FLOW MEDIATED DILATATION; HUMAN; HYPEREMIA; LASER DOPPLER FLOWMETRY; LOW DRUG DOSE; NON INVASIVE PROCEDURE; PARACRINE SIGNALING; PERIPHERAL CIRCULATION; PLETHYSMOGRAPHY; PRIORITY JOURNAL; PULSE WAVE; REPRODUCIBILITY; REVIEW; SENSITIVITY AND SPECIFICITY; SEX DIFFERENCE; STEM CELL; TONOMETRY; TREATMENT RESPONSE; VASODILATATION; BLOOD; ECHOGRAPHY; MUSCLE TONE; PATHOPHYSIOLOGY; VASCULAR DISEASE; VASCULAR ENDOTHELIUM;

ADRENERGIC BETA-AGONISTS; BIOLOGICAL MARKERS; ENDOTHELIUM, VASCULAR; HUMANS; LASER-DOPPLER FLOWMETRY; MUSCLE TONUS; SENSITIVITY AND SPECIFICITY; VASCULAR DISEASES; VASODILATION;

EID: 61449136198     PISSN: 13816128     EISSN: None     Source Type: Journal    
DOI: 10.2174/138161208786898761     Document Type: Review

References (71)

1. Furchgott RF, Zawadzki JV. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 1980; 288: 373-6.
2. Luscher TF, Vanhoutte PM. The endothelium: Modulator of cardiovascular function, CRC Press: Boca Raton 1990
3. Cohen RA, Vanhoutte PM. Endothelium-dependent hyperpolarization. Beyond nitric oxide and cyclic GMP. Circulation 1995; 92: 3337-49.
4. Taddei S, Ghiadoni L, Virdis A, Buralli S, Salvetti A. Vasodilation to bradykinin is mediated by an ouabain-sensitive pathway as a compensatory mechanism for impaired nitric oxide availability in essential hypertensive patients. Circulation 1999; 100: 1400-5.
5. Ross R. Atherosclerosis - an inflammatory disease. N Engl J Med 1999; 340: 115-26.
6. Deanfield J, Donald A, Ferri C, Giannattasio C, Halcox J, Halligan S, et al. Endothelial function and dysfunction. Part I: Methodological issues for assessment in the different vascular beds: A statement by the Working Group on Endothelin and Endothelial Factors of the European Society of Hypertension. J Hypertens 2005; 23: 7-17.
7. Deanfield JE, Halcox JP, Rabelink TJ. Endothelial function and dysfunction: Testing and clinical relevance. Circulation 2007; 115: 1285-95.
8. Taddei S, Virdis A, Ghiadoni L, Magagna A, Salvetti A. Vitamin C improves endothelium-dependent vasodilation by restoring nitric oxide activity in essential hypertension. Circulation 1998; 97: 2222-9.
9. Celermajer DS, Sorensen KE, Gooch VM, Spiegelhalter DJ, Miller OI, Sullivan ID, et al. Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet 1992; 340: 1111-5.
10. Joannides R, Haefeli WE, Linder L, Richard V, Bakkali EH, Thuillez C, et al. Nitric oxide is responsible for flow-dependent dilatation of human peripheral conduit arteries in vivo. Circulation 1995; 91: 1314-9.
11. Ghiadoni L, Versari D, Magagna A, Kardasz I, Plantinga Y, Giannarelli C, et al. Ramipril dose-dependently increases nitric oxide availability in the radial artery of essential hypertension patients. J Hypertens 2007; 25: 361-6.
12. Brunner H, Cockcroft JR, Deanfield J, Donald A, Ferrannini E, Halcox J, et al. Endothelial function and dysfunction. Part II: Association with cardiovascular risk factors and diseases. A statement by the Working Group on Endothelins and Endothelial Factors of the European Society of Hypertension. J Hypertens 2005; 23: 233-46.
13. Ghiadoni L, Penno G, Giannarelli C, Plantinga Y, Bernardini M, Pucci L, et al. Metabolic syndrome and vascular alterations in normotensive subjects at risk of diabetes mellitus. Hypertension 2008; 51: 440-5.
14. Plantinga Y, Ghiadoni L, Magagna A, Giannarelli C, Franzoni F, Taddei S, et al. Supplementation with vitamins C and e improves arterial stiffness and endothelial function in essential hypertensive patients. Am J Hypertens 2007; 20: 392-7.
15. Ghiadoni L, Magagna A, Versari D, Kardasz I, Huang Y, Taddei S, et al. Different effect of antihypertensive drugs on conduit artery endothelial function. Hypertension 2003; 41: 1281-6.
16. Juonala M, Viikari JS, Laitinen T, Marniemi J, Helenius H, Ronnemaa T, et al. Interrelations between brachial endothelial function and carotid intima-media thickness in young adults: The cardiovascular risk in young Finns study. Circulation 2004; 110: 2918-23.
17. Rundek T, Hundle R, Ratchford E, Ramas R, Sciacca R, Di Tullio MR, et al. Endothelial dysfunction is associated with carotid plaque: A cross-sectional study from the population based Northern Manhattan Study. BMC Cardiovasc Disord 2006; 6: 35.
18. Lerman A, Zeiher AM. Endothelial function: Cardiac events. Circulation 2005; 111: 363-8.
19. Benjamin EJ, Larson MG, Keyes MJ, Mitchell GF, Vasan RS, Keaney JF, Jr., et al. Clinical correlates and heritability of flow-mediated dilation in the community: The Framingham Heart Study. Circulation 2004; 109: 613-9.
20. Witte DR, Westerink J, de Koning EJ, van der Graaf Y, Grobbee DE, Bots ML. Is the association between flow-mediated dilation and cardiovascular risk limited to low-risk populations? J Am Coll Cardiol 2005; 45: 1987-93.
21. Corretti MC, Anderson TJ, Benjamin EJ, Celermajer D, Charbonneau F, Creager MA, et al. Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: a report of the International Brachial Artery Reactivity Task Force. J Am Coll Cardiol 2002; 39: 257-65.
22. Ghiadoni L, Donald AE, Cropley M, Mullen MJ, Oakley G, Taylor M, et al. Mental stress induces transient endothelial dysfunction in humans. Circulation 2000; 102: 2473-8.
23. Beux F, Carmassi S, Salvetti MV, Ghiadoni L, Huang Y, Taddei S, et al. Automatic evaluation of arterial diameter variation from vascular echographic images. Ultrasound Med Biol 2001; 27: 1621-9.
24. Sonka M, Liang W, Lauer RM. Automated analysis of brachial ultrasound image sequences: Early detection of cardiovascular disease via surrogates of endothelial function. IEEE Trans Med Imaging 2002; 21: 1271-9.
25. Frangi AF, Laclaustra M, Lamata P. A registration-based approach to quantify flow-mediated dilation (FMD) of the brachial artery in ultrasound image sequences. IEEE Trans Med Imaging 2003; 22: 1458-69
26. Craiem D, Chironi G, Gariepy J, Miranda-Lacet J, Levenson J, Simon A. New monitoring software for larger clinical application of brachial artery flow-mediated vasodilatation measurements. J Hypertens 2007; 25: 133-40.
27. Gemignani V, Bianchini E, Faita F, Giannarelli C, Plantinga Y, Ghiadoni L, et al. Ultrasound Measurement of the Brachial Artery Flow-Mediated Dilation without Ecg Gating. Ultrasound Med Biol 2007; 25: 25.
28. Gemignani V, Faita F, Ghiadoni L, Poggianti E, Demi M. A system for real-time measurement of the brachial artery diameter in B-mode ultrasound images. IEEE Trans Med Imaging 2007; 26: 393- 404.
29. Donald AE, Halcox JP, Charakida M, Storry C, Wallace SM, Cole TJ, et al. Methodological approaches to optimize reproducibility and power in clinical studies of flow-mediated dilation. J Am Coll Cardiol 2008; 51: 1959-64.
30. Hoeks AP, Brands PJ, Smeets FA, Reneman RS. Assessment of the distensibility of superficial arteries. Ultrasound Med Biol 1990; 16: 121-8.
31. Ghiadoni L. Change in forearm reactive hyperemia after telmisartan: An endothelial effect? Am J Hypertens 2007; 20: 1312-3.
32. Pyke KE, Tschakovsky ME. Peak vs. total reactive hyperemia: Which determines the magnitude of flow-mediated dilation? J Appl Physiol 2007; 102: 1510-9.
33. Ghiadoni L, Huang Y, Magagna A, Buralli S, Taddei S, Salvetti A. Effect of acute blood pressure reduction on endothelial function in the brachial artery of patients with essential hypertension. J Hypertens 2001; 19: 547-51.
34. Higashi Y, Sasaki S, Nakagawa K, Matsuura H, Kajiyama G, Oshima T. A noninvasive measurement of reactive hyperemia that can be used to assess resistance artery endothelial function in humans. Am J Cardiol 2001; 87: 121-5, A9.
35. Chowienczyk PJ, Kelly RP, MacCallum H, Millasseau SC, Andersson TL, Gosling RG, et al. Photoplethysmographic assessment of pulse wave reflection: Blunted response to endothelium-dependent beta2-adrenergic vasodilation in type II diabetes mellitus. J Am Coll Cardiol 1999; 34: 2007-14.
36. Kuvin JT, Patel AR, Sliney KA, Pandian NG, Sheffy J, Schnall RP, et al. Assessment of peripheral vascular endothelial function with finger arterial pulse wave amplitude. Am Heart J 2003; 146: 168-74.
37. Nohria A, Gerhard-Herman M, Creager MA, Hurley S, Mitra D, Ganz P. Role of nitric oxide in the regulation of digital pulse volume amplitude in humans. J Appl Physiol 2006; 101: 545-8.
38. Bonetti PO, Pumper GM, Higano ST, Holmes DR, Jr., Kuvin JT, Lerman A. Noninvasive identification of patients with early coronary atherosclerosis by assessment of digital reactive hyperemia. J Am Coll Cardiol 2004; 44: 2137-41.
39. Hamburg NM, Keyes MJ, Larson MG, Vasan RS, Schnabel R, Pryde MM, et al. Cross-sectional relations of digital vascular function to cardiovascular risk factors in the Framingham Heart Study. Circulation 2008; 117: 2467-74.
40. Wilkinson IB, Hall IR, MacCallum H, Mackenzie IS, McEniery CM, van der Arend BJ, et al. Pulse-wave analysis: Clinical evaluation of a noninvasive, widely applicable method for assessing endothelial function. Arterioscler Thromb Vasc Biol 2002; 22: 147-52.
41. Hayward CS, Kraidly M, Webb CM, Collins P. Assessment of endothelial function using peripheral waveform analysis: A clinical application. J Am Coll Cardiol 2002; 40: 521-8.
42. Rambaran C, Jiang B, Ritter JM, Shah A, Kalra L, Chowienczyk PJ. Assessment of endothelial function: Comparison of the pulse wave response to beta 2-adrenoceptor stimulation with flow mediated dilatation. Br J Clin Pharmacol 2008; 65: 238-43.
43. Donald AE, Charakida M, Cole TJ, Friberg P, Chowienczyk PJ, Millasseau SC, et al. Non-invasive assessment of endothelial function: Which technique? J Am Coll Cardiol 2006; 48: 1846-50.
44. Cracowski JL, Minson CT, Salvat-Melis M, Halliwill JR. Methodological issues in the assessment of skin microvascular endothelial function in humans. Trends Pharmacol Sci 2006; 27: 503-8.
45. Wong BJ, Wilkins BW, Holowatz LA, Minson CT. Nitric oxide synthase inhibition does not alter the reactive hyperemic response in the cutaneous circulation. J Appl Physiol 2003; 95: 504-10.
46. Binggeli C, Spieker LE, Corti R, Sudano I, Stojanovic V, Hayoz D, et al. Statins enhance postischemic hyperemia in the skin circulation of hypercholesterolemic patients: A monitoring test of endothelial dysfunction for clinical practice? J Am Coll Cardiol 2003; 42: 71-7
47. Charkoudian N. Skin blood flow in adult human thermoregulation: How it works, when it does not, and why. Mayo Clin Proc 2003; 78: 603-12.
48. Christen S, Delachaux A, Dischl B, Golay S, Liaudet L, Feihl F, et al. Dose-dependent vasodilatory effects of acetylcholine and local warming on skin microcirculation. J Cardiovasc Pharmacol 2004; 44: 659-64.
49. Minson CT, Berry LT, Joyner MJ. Nitric oxide and neurally mediated regulation of skin blood flow during local heating. J Appl Physiol 2001; 91: 1619-26.
50. Holowatz LA, Thompson CS, Minson CT, Kenney WL. Mechanisms of acetylcholine-mediated vasodilatation in young and aged human skin. J Physiol 2005; 563: 965-73.
51. Kvandal P, Stefanovska A, Veber M, Kvernmo HD, Kirkeboen KA. Regulation of human cutaneous circulation evaluated by laser Doppler flowmetry, iontophoresis, and spectral analysis: Importance of nitric oxide and prostaglandines. Microvasc Res 2003; 65: 160-71.
52. Rassaf T, Feelisch M, Kelm M. Circulating NO pool: Assessment of nitrite and nitroso species in blood and tissues. Free Radic Biol Med 2004; 36: 413-22.
53. Vallance P, Leiper J. Cardiovascular biology of the asymmetric dimethylarginine: Dimethylarginine dimethylaminohydrolase pathway. Arterioscler Thromb Vasc Biol 2004; 24: 1023-30.
54. Boger RH, Maas R, Schulze F, Schwedhelm E. Elevated levels of asymmetric dimethylarginine (ADMA) as a marker of cardiovascular disease and mortality. Clin Chem Lab Med 2005; 43: 1124-9.
55. Goon PK, Boos CJ, Lip GY. Circulating endothelial cells: Markers of vascular dysfunction. Clin Lab 2005; 51: 531-8.
56. Fujiyama S, Amano K, Uehira K, Yoshida M, Nishiwaki Y, Nozawa Y, et al. Bone marrow monocyte lineage cells adhere on injured endothelium in a monocyte chemoattractant protein-1-dependent manner and accelerate reendothelialization as endothelial progenitor cells. Circ Res 2003; 93: 980-9.
57. Murohara T, Asahara T, Silver M, Bauters C, Masuda H, Kalka C, et al. Nitric oxide synthase modulates angiogenesis in response to tissue ischemia. J Clin Invest 1998; 101: 2567-78.
58. Werner N, Kosiol S, Schiegl T, Ahlers P, Walenta K, Link A, et al. Circulating endothelial progenitor cells and cardiovascular outcomes. N Engl J Med 2005; 353: 999-1007.
59. Anderson TJ, Uehata A, Gerhard MD, Meredith IT, Knab S, Delagrange D, et al. Close relation of endothelial function in the human coronary and peripheral circulations. J Am Coll Cardiol 1995; 26: 1235-41.
60. Grover SA, Lowensteyn I, Kaouache M, Marchand S, Coupal L, DeCarolis E, et al. The prevalence of erectile dysfunction in the primary care setting: Importance of risk factors for diabetes and vascular disease. Arch Intern Med 2006; 166: 213-9.
61. Thompson IM, Tangen CM, Goodman PJ, Probstfield JL, Moinpour CM, Coltman CA. Erectile dysfunction and subsequent cardiovascular disease. JAMA 2005; 294: 2996-3002.
62. Solomon H, Man JW, Jackson G. Erectile dysfunction and the cardiovascular patient: Endothelial dysfunction is the common denominator. Heart 2003; 89: 251-3.
63. Vlachopoulos C, Aznaouridis K, Ioakeimidis N, Rokkas K, Tsekoura D, Vasiliadou C, et al. Arterial function and intima-media thickness in hypertensive patients with erectile dysfunction. J Hypertens 2008; 26: 1829-36.
64. Vlachopoulos C, Hirata K, O'Rourke MF. Effect of sildenafil on arterial stiffness and wave reflection. Vasc Med 2003; 8: 243-8.
65. Rosano GM, Aversa A, Vitale C, Fabbri A, Fini M, Spera G. Chronic treatment with tadalafil improves endothelial function in men with increased cardiovascular risk. Eur Urol 2005; 47: 214-20.
66. Aversa A, Greco E, Bruzziches R, Pili M, Rosano G, Spera G. Relationship between chronic tadalafil administration and improvement of endothelial function in men with erectile dysfunction: A pilot study. Int J Impot Res 2007; 19: 200-7.
67. Aversa A, Sarteschi LM. The role of penile color-duplex ultrasound for the evaluation of erectile dysfunction. J Sex Med 2007; 4: 1437-47.
68. Virag R. Flow-dependent dilatation of the cavernous artery. A potential test of penile NO content. J Mal Vasc 2002; 27: 214-7.
69. Virag R, Floresco J, Richard C. Impairment of shear-stressmediated vasodilation of cavernous arteries in erectile dysfunction. Int J Impot Res 2004; 16: 39-42.
70. Mazo E, Gamidov S, Anranovich S, Iremashvili V. Testing endothelial function of brachial and cavernous arteries in patients with erectile dysfunction. J Sex Med 2006; 3: 323-30.
71. Mazo E, Gamidov S, Iremashvili V. The effect of vardenafil on endothelial function of brachial and cavernous arteries. Int J Impot Res 2006; 18: 464-9.